Harmony Biosciences Holdings, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net income was USD 21.49 million compared to USD 7.39 million a year ago. Basic earnings per share from continuing operations was USD 0.36 compared to USD 0.13 a year ago. Diluted earnings per share from continuing operations was USD 0.35 compared to USD 0.13 a year ago.